Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

45.71 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Catalent Appoints David McErlane as Biologics Segment Leader
From Catalent, Inc.
Via Business Wire
15 Analysts Have This to Say About Catalent
Via Benzinga
Catalent Earnings Preview
Via Benzinga
What 19 Analyst Ratings Have To Say About Catalent
Via Benzinga
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
From Catalent, Inc.
Via Business Wire
3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late
With debt getting more expensive, it’s become easier to recommend unloading these three S&P 500 stocks now. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Catalent, Inc. to Present at September Investor Conferences
From Catalent, Inc.
Via Business Wire
Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
Why Catalent Stock Zoomed 12% Higher This Week
A strong earnings report and a clutch of analyst price target hikes will do that. 
Via The Motley Fool
Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says
Tuesday, Catalent Inc (NYSE: CTLT) reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the  
Via Benzinga
RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know
Via Benzinga
Why Catalent Stock Surged Nearly 5% Higher Today
Fourth-quarter performance that wasn't too disappointing, plus a settlement with an activist investor, brought some bulls back to the company's shares. 
Via The Motley Fool
Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count
Workhorse (WKHS) stock is on the move Tuesday after the company failed to get shareholder approval to increase its share count. 
Via InvestorPlace
Can a New CFO Save Canoo (GOEV) Stock?
Canoo (GOEV) stock is getting a boost on Tuesday as investors react to the company naming its new Chief Financial Officer. 
Via InvestorPlace
ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?
Oracle (ORCL) stock is in the news Tuesday as UBS analyst Karl Keirstead makes a bull case for the information technology company's shares. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories
Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm 
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Catalent (CTLT) Stock Gains on Elliott Deal
Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management. 
Via InvestorPlace
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.  
Via Benzinga
Exposures COVID-19
Catalent Announces Governance Enhancements and New Initiatives to Drive Value
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
From Catalent, Inc.
Via Business Wire
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its  
Via Benzinga
Why Novo Nordisk Stock Was Racing Higher on Wednesday
When you have a hot item on the market, it's wise to ramp up production. 
Via The Motley Fool
One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
Novo Nordisk A/S (NYSE: NVO) has reportedly enlisted the services of Thermo Fisher Scientific Inc (NYSE: TMO) as its second contract manufacturer for its highly sought-after  
Via Benzinga
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Is Regeneron Pharmaceuticals Moving Higher Today?
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre 
Via Benzinga
Rising Dividend Make Zoetis a Doggone Winner
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis. 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.